Showing 1181-1190 of 9920 results for "".
Care for Skin of Color: Hope on the Horizon
https://practicaldermatology.com/topics/skin-cancer-photoprotection/care-for-skin-of-color-hope-on-the-horizon/20562/Experts address new and emerging options to treat a growing patient population in the US.Physician Spotlight With Latanya Benjamin, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-with-latanya-benjamin-md/23950/Physician Spotlight: Meena Singh, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-meena-singh/23939/When Our Health Care System Injures the Physician’s Soul
https://practicaldermatology.com/topics/practice-management/when-our-health-care-system-injures-the-physicians-soul/23845/One dermatologist’s quest to protect physicians from moral injury.Physician Spotlight With A. Yasmine Kirkorian, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-with-a-yasmine-kirkorian-md/23082/A Closer Look at Skyrizi
https://practicaldermatology.com/columns/clinical-focus-1/a-closer-look-at-skyrizi/23016/The newest IL-23 blocker for psoriasis may prove to be a blockbuster, according to analysts.More Advice for Residents; AMA Calls for More Residency Slots; Call for Submissions
https://practicaldermatology.com/youngmd-connect/resident-resource-center/more-advice-for-residents-ama-calls-for-more-residency-slots-call-for-submissions/20437/A Review of Incident to Services
https://practicaldermatology.com/topics/practice-management/a-review-of-incident-to-services/20526/In order to ensure correct billing—and reimbursements—it is important to understand incident to policies.Physician Spotlight: Richard Odom, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight/20702/Revelations and reflections on the pathogenesis and etiology of rosacea.Biosimilars: Generic Biologics or Something Much More Complex?
https://practicaldermatology.com/topics/practice-management/biosimilars-generic-biologics-or-something-much-more-complex/21013/The looming availability of biosimilar medications raises important clinical and regulatory questions.